Skip to content

CARDIONEXT

Active Private limited companyfounded 2014active for 12 yearsRue du Berger 1, 1428 Braine-l'AlleudKBO/BCE: BE 0548.731.473

Lifetime

11 annual accounts with figures on one time axis
peak of €235,939 in 2015
€203,202▼ 9.6%
peak of €126,282 in 2024
€116,533▼ 7.7%
peak of €171,478 in 2017
€21,682▼ 79.0%
€564,537▲ 16.4%
Board2 names since 2014
2 directors and 1 other
Documentsfilings and deeds
14-04-202616 days before the deadline
2025micro format
Dividend €198,000Equity from €103,149 to €21,682Debts from €484,963 to €564,537

Key points

from the 2025 annual accounts

Equity

€21,682 from €171,478 in 2017

Equity fell by 87% in 8 years.

Debts

€564,537 96% of the balance sheet
Financial debts 23%Suppliers 1%Taxes and wages 1%Other 76%

Of this, €455,606 falls due within a year.

Filings

11 annual accounts since 2015
deadline201520202025

Five of the last ten came late. The 2021 accounts came in latest, 88 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 537 companies had the same profile as CARDIONEXT has now. Each dot stands for 2 companies, two years later.

95.9%
were still trading
3.4%
stopped another way
0.7%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 537 companies, not a prediction for CARDIONEXT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager, since 20-03-2014
Director, since 20-03-2014
  • all the sharesdeed of 20-12-2023

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0548731473
Registered office moved within Braine-l'Alleud The registered office moved from 1428 Braine-l'Alleud (Lillois-Witterzée) rue du Berger 1 to rue du Berger 1, 1428 Braine-l'Alleud (Lillois-Witterzée) · changes role from manager to director · “La société a également pour activité la création de contenus informatifs et pédagogiques, centrés sur…” (deed in French) · General meeting of 11-12-2023 · Gazette deed
General meeting of 10-04-2014 Gazette deed
Registered office moved from Lillois to Mont-sur-Marchienne The registered office moved from rue du Bergen1, à B-1428 Lillois to Avenue Astrid 9, à B-6032 Mont-sur-Marchienne · General meeting of 12-06-2014 · Gazette deed
All 22 events

Official details

Source: KBO
Status
Active since 20-03-2014Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 5 activities
Establishment unit
2.228.525.6096032 Charleroi, since 20-03-2014
Financial year end
30 September
Peppol
Reachable since 12-12-2025
Company details

Annual accounts to 30-09-2025

≈ €500,000estimated
€586,219▼ 0.3%
Filing
Filed on 14-04-2026, 16 days before the end of the filing period
Financials

Insights on CARDIONEXT

CARDIONEXT files the micro format. That format states no turnover. The gross margin fell from €235,939 in 2015 to €203,202 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about CARDIONEXT

What is the company number of CARDIONEXT?
The company number of CARDIONEXT is 0548.731.473. The VAT number is the same number with BE in front: BE 0548.731.473.
Where is CARDIONEXT based?
The registered office is at Rue du Berger 1, 1428 Braine-l'Alleud.Company details
What does CARDIONEXT do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of CARDIONEXT?
CARDIONEXT is a private limited company (BV).
When was CARDIONEXT founded?
CARDIONEXT was founded on 20-03-2014.
Is CARDIONEXT still active?
Yes, CARDIONEXT is an active enterprise in the KBO register.
What is the turnover of CARDIONEXT?
The turnover in financial year 2025 is about €500,000. This figure is estimated from the gross margin of €203,202 and 2,458 comparable companies of the same size. It probably lies between €340,000 and €790,000. It is a rough estimate.Financials
Is CARDIONEXT profitable?
In financial year 2025, CARDIONEXT made a profit of €116,533.
Where can I find the annual accounts of CARDIONEXT?
CARDIONEXT filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of CARDIONEXT due?
CARDIONEXT must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.